The Venture Capital Podcast with Fexingo: VCs, Term Sheets, and Startup Investing

This episode of The Venture Capital Podcast looks at why VCs are pouring money into care economy startups—companies tackling eldercare, childcare, and caregiving logistics. Lucas and Luna break down the numbers: how the aging population and women's workforce participation are driving demand, and why venture firms are backing infrastructure over platforms. They reference the ARK Genomics ETF's 13.8...

In this episode of The Venture Capital Podcast, Lucas and Luna break down a controversial tax strategy gaining traction among venture capitalists this year: the Section 83(i) election for startup equity. They explain how founders and early employees at eligible companies can defer taxes on stock options for up to five years, and why some VCs are now structuring deals to facilitate this election as...

Lucas and Luna dive into the murky world of startup IP valuation—why it's suddenly a battleground in term sheets as AI models trained on proprietary data create trillion-dollar questions. They unpack a specific case: how a health-tech startup's patent portfolio shifted their Series A valuation by 30 percent, and why VCs are now hiring IP specialists to diligence deals. Plus, the hosts discuss how...

Episode 77 of The Venture Capital Podcast with Fexingo dives into the booming defense tech sector in 2026. Lucas and Luna explore why venture capital is flowing into startups building military and security solutions, from AI-powered surveillance to autonomous drones. They examine recent headlines like the FTC's approval of Musk's acquisition of SpaceX alumni startup Mesh and the Trump administrati...

Episode 76 of The Venture Capital Podcast. Lucas and Luna explore why top venture capital firms are pouring hundreds of millions into gene therapy manufacturing — a space historically dominated by a few contract development and manufacturing organizations (CDMOs). They zero in on the specific bottleneck: viral vector production, which costs startups up to $400,000 per batch and can delay clinical...

Episode 75 of The Venture Capital Podcast dives into a quiet but massive shift in biotech venture capital: gene therapy manufacturing. While most headlines chase AI and crypto, VCs are placing billion-dollar bets on the infrastructure that produces living drugs. Lucas and Luna unpack why gene therapy factories are the new semiconductor fabs, with a focus on the recent $200 million Series C for a s...

This episode of The Venture Capital Podcast digs into a quiet shift in venture capital: energy infrastructure. Lucas and Luna look at a16z-backed Base Power, which is offering cheaper electricity to the grid, and the broader thesis that VCs are moving beyond pure software into hard-tech energy plays. They discuss why the AI data-center boom is driving demand for new power sources, how startups lik...

In episode 73 of The Venture Capital Podcast, Lucas and Luna examine a quiet shift in how venture firms spend their time: the move from constant fundraising toward building fund operations teams. Using recent data on ARK Genomic Revolution ETF's 10% weekly surge and Palantir's 13% drop as a lens, they discuss why general partners are hiring operations partners, CFOs, and portfolio success teams ea...

In this episode of The Venture Capital Podcast, Lucas and Luna examine the shift from general-purpose AI assistants to industry-specific copilots. They discuss how VCs are backing startups building AI tools for under-digitized sectors like construction, agriculture, and logistics. Using recent data—ARKG up 10.5% over five days and a new Facebook AI companion app—they explore why narrow, domain-spe...

This episode of The Venture Capital Podcast with Fexingo explores a surprising new frontier in venture capital: construction robotics. Lucas and Luna discuss why top-tier VCs are pouring capital into startups that automate building sites, from bricklaying robots to autonomous dozers. They anchor the conversation on a specific case—Menlo Ventures' recent $3 billion fund raise after betting big on A...

In this episode of The Venture Capital Podcast with Fexingo, Lucas and Luna explore why top venture firms are shifting their focus from funding AI model companies to investing in the physical and digital infrastructure that powers them. They break down the recent GPU supply glut, the rise of data-center REITs, and the strategic pivot of firms like a16z and Sequoia toward energy, networking, and co...

In Episode 69 of The Venture Capital Podcast, Lucas and Luna dissect the concept of 'founder friendliness' and how VCs leverage it as a strategic tool. Drawing on June 2026 data, they explore why supposedly friendly terms can lock founders into unfavorable structures, using recent cases like Palantir's slide and Airbnb's steady performance. Lucas explains how VCs use narrative control to shape per...

In this episode of The Venture Capital Podcast, Lucas and Luna explore why top-tier VCs are now scrutinizing revenue concentration as a key risk metric in 2026. They break down a specific case study—a B2B SaaS startup that hit $10 million ARR but had 70% of revenue from a single enterprise client—and show how a diversification clause is quietly appearing in term sheets. With Amazon's Alexa+ expans...

In this episode of The Venture Capital Podcast, Lucas and Luna unpack the pro rata clause — a term sheet provision that lets existing investors maintain their ownership percentage in future funding rounds. They explore how top-tier VCs use pro rata to block new investors, drive up valuations, and secure their position in high-growth startups. Using real data from recent rounds and the current mark...

In this episode of The Venture Capital Podcast, Lucas and Luna explore the rise of rolling funds—a relatively new structure that lets VCs raise capital continuously instead of in fixed vintage years. Drawing on AngelList data showing rolling fund AUM surpassing $15 billion in early 2026, they discuss how this model gives GPs more flexibility and allows LPs to drip-feed commitments. But there are t...

In this episode of The Venture Capital Podcast with Fexingo, Lucas and Luna explore the mechanics behind a new wave of VC funding in synthetic biology. They anchor on the recent 10.1% weekly jump in ARKG, Cathie Wood's genomics ETF, and the $2.8 billion Series C raised by Ginkgo Bioworks. Lucas breaks down why top firms like Founders Fund and Andreessen Horowitz are placing big bets on syn-bio, co...

Lucas and Luna examine a quiet but growing trend in early-stage venture capital: VCs asking founders for 'earnest money'—a small cash deposit paid by the startup at signing to secure a term sheet, typically refundable only if the investor walks. Lucas traces the practice to a handful of high-demand rounds in early 2026, citing data from a leaked side letter at a Bay Area AI startup. Luna challenge...

In this episode of The Venture Capital Podcast, Lucas and Luna unpack the roll-up strategy that VCs are quietly using to turn fragmented markets into platform companies. They focus on the case of Mythos, a robotics startup that just raised a $200 million Series C to acquire its way to dominance — a playbook borrowed from Vista Equity Partners and Thoma Bravo. The hosts discuss how this approach di...

Lucas and Luna dig into the quiet rise of continuation funds, where VCs sell portfolio companies to themselves rather than letting outside buyers in. On this episode of The Venture Capital Podcast, they trace the mechanics through a real 2025 deal: a $400 million health-tech rollup orchestrated by a top-tier firm. They explain why limited partners are getting squeezed, how the SEC is starting to p...

Lucas and Luna dig into a term sheet detail that founders often breeze past: the reference call. Not the informal chatter with other investors, but the structured diligence that can reveal whether a board member adds value or adds friction. Lucas shares a story about a late-stage startup that nearly took a term sheet from a top-tier firm, only to discover through three strategic reference calls th...

In Episode 60 of The Venture Capital Podcast, Lucas and Luna explore an uncomfortable reality of early-stage investing in mid-2026: the widening gap between what founders think their Series A is worth and what VCs are actually paying. Using fresh data from the recent IPO filings of companies like Reddit and the performance of ARKK (up 4.6% in five days), they break down how down rounds are becomin...

Snap's stock tumbled 12% after unveiling $1,500 AR glasses that critics called a 'developer demo masquerading as a product.' But Lucas and Luna dig into why several top-tier venture firms are quietly doubling down on augmented reality hardware — and how a contrarian thesis from Chi-Hua Chien suggests the real AI winners won't be selling AI at all. They break down the numbers: Snap's AR hardware in...

Episode 58 of The Venture Capital Podcast with Fexingo. Lucas and Luna dig into a structural shift in how VCs source deals: the rise of AI-native deal flow tools. They explore how firms like Sequoia and a16z are using internal large language models to scan startup databases, pitch decks, and social signals for patterns humans miss. Lucas cites new data from a 2026 survey by the National Venture Ca...

In this episode of The Venture Capital Podcast, Lucas and Luna examine how SoftBank's return to mega-fundraising is reshaping late-stage startup valuations in mid-2026. They discuss the $2.6 trillion SpaceX valuation, the surge in ARK Innovation ETF, and the implications for founders and VCs navigating a market where Vision Fund-sized checks are back. Lucas walks through SoftBank's $30 billion Vis...

When a startup gets acquired, the headline price often includes earnouts—contingent payments tied to future milestones. This episode unpacks why earnouts are increasingly common in 2026's M&A landscape, using the recent case of a well-known AI startup acquisition where founders lost millions because earnout targets were missed. Lucas explains how earnouts shift risk from buyer to seller, why ventu...